Letter to the editor
Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples

https://doi.org/10.1016/j.jaci.2010.02.005Get rights and content

References (9)

There are more references available in the full text version of this article.

Cited by (61)

  • Endotype-driven approach for asthma

    2018, Implementing Precision Medicine in Best Practices of Chronic Airway Diseases
View all citing articles on Scopus

Disclosure of potential conflict of interest: R. Olivenstein is on the advisory boards for GlaxoSmithKline and AstraZeneca, receives lecture fees from Boehringer-Ingelheim, and receives research support from MedImmune and Novartis. C. Lemière receives research support from the Centers for Disease Control and Prevention and the Quebec Occupational Health and Safety Research Institute (IRSST) and participates on advisory committees for GlaxoSmithKline and AstraZeneca. P. Nair receives research support from Schering-Plough and Ception, Inc. The rest of the authors have declared that they have no conflict of interest.

This study and the Difficult Asthma Program are supported by the Richard and Edith Strauss Canada Foundation. The Meakins-Christie Laboratories and McGill University Health Centre Research Institute are supported in part by a Center grant from Le Fonds de la Recherche en Santé du Québec and the J.T. Costello Memorial Research Fund.

View full text